Status:

COMPLETED

ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

Lead Sponsor:

Centre Hospitalier Régional Metz-Thionville

Collaborating Sponsors:

centre régional de pharmacovigilance de Nancy

Theradial

Conditions:

Catheter-Related Infections

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to compare the efficacy of a lock taurolidine-citrate solution vs standard saline solution for primary prevention of central venous catheter-associated bloodstream infecti...

Detailed Description

The central venous catheter (CVC)-associated bloodstream infection (CLABSI) represent a serious and persistent health problem in cancer patients with an implantable CVC receiving an intravenous (IV) a...

Eligibility Criteria

Inclusion

  • Patients older than 18 years
  • Performance Index (WHO score) ≤ 2
  • Patient with a solid cancer receiving an IV anti-tumor treatment
  • Presence of a totally implantable CVC
  • Anti-tumoral therapy administered by a totally implantable CVC
  • Metastatic and / or (neo) adjuvant treatment
  • Full hospitalised and / or day-hospital patients
  • Informed written consent
  • Social Health security insurance

Exclusion

  • Hematological cancer patients
  • HIV-positive patients and/ or patients receiving an active immunosuppressive therapy
  • Patients presenting a febrile episode within 4 days prior to randomisation
  • Patients with neutropenia grade ≥ 2 (ANC ≤ 1000/mm3) on a blood testing older than 7 days
  • Patients on IV antibiotic therapy
  • Patients on total and / or peripheral parental nutrition
  • Patients with a previous CLABSI history
  • Allergy to citrate or taurolidine
  • Patients who are not able to give an informed consent
  • Patients under guardianship
  • Patients under judicial protection
  • Pregnant or breastfeeding woman

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2016

Estimated Enrollment :

162 Patients enrolled

Trial Details

Trial ID

NCT02279121

Start Date

November 1 2014

End Date

March 1 2016

Last Update

August 26 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chr Metz Thionville

Metz, France, 57085